Thu, August 1, 2024

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, Aug 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-15-on-aug-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, Aug 1st, 2024.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Edward Tenthoff of "Piper Sandler" Reiterated at Buy and Held Target at $13 on, Wednesday, April 3rd, 2024

Publication Contributing Sources